Amphastar Pharmaceuticals, Inc. (AMPH)
21.51
-0.09
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
21.51
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals EPS Diluted (Quarterly) : 0.6862 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6862 |
| March 31, 2026 | 0.1382 |
| December 31, 2025 | 0.518 |
| September 30, 2025 | 0.3639 |
| June 30, 2025 | 0.6447 |
| March 31, 2025 | 0.5068 |
| December 31, 2024 | 0.7399 |
| September 30, 2024 | 0.7796 |
| June 30, 2024 | 0.7291 |
| March 31, 2024 | 0.8145 |
| December 31, 2023 | 0.6822 |
| September 30, 2023 | 0.9128 |
| June 30, 2023 | 0.492 |
| March 31, 2023 | 0.5009 |
| December 31, 2022 | 0.6558 |
| September 30, 2022 | 0.3007 |
| June 30, 2022 | 0.3259 |
| March 31, 2022 | 0.4666 |
| December 31, 2021 | 0.3948 |
| September 30, 2021 | 0.5908 |
| June 30, 2021 | 0.1567 |
| March 31, 2021 | 0.1018 |
| December 31, 2020 | -0.1321 |
| September 30, 2020 | 0.0786 |
| June 30, 2020 | -0.0041 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0819 |
| December 31, 2019 | -0.0219 |
| September 30, 2019 | 0.0262 |
| June 30, 2019 | 0.9578 |
| March 31, 2019 | 0.0172 |
| December 31, 2018 | 0.038 |
| September 30, 2018 | 0.0495 |
| June 30, 2018 | -0.0613 |
| March 31, 2018 | -0.1535 |
| December 31, 2017 | 0.016 |
| September 30, 2017 | 0.0036 |
| June 30, 2017 | 0.04 |
| March 31, 2017 | 0.02 |
| December 31, 2016 | -0.06 |
| September 30, 2016 | 0.08 |
| June 30, 2016 | 0.15 |
| March 31, 2016 | 0.05 |
| December 31, 2015 | 0.16 |
| September 30, 2015 | -0.07 |
| June 30, 2015 | -0.15 |
| March 31, 2015 | -0.01 |
| December 31, 2014 | -0.06 |
| September 30, 2014 | -0.12 |
| June 30, 2014 | -0.03 |
| March 31, 2014 | -0.0373 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | -1.005 |
| Liquidia Corp. | 0.7369 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 30.35M |
| Revenue (Quarterly) | 183.90M |
| Total Expenses (Quarterly) | 153.56M |
| Enterprise Value | 1.314B |
| Gross Profit Margin (Quarterly) | 48.73% |
| Profit Margin (Quarterly) | 16.50% |
| Earnings Yield | 7.93% |
| Operating Earnings Yield | 11.46% |
| Normalized Earnings Yield | 7.024 |